Literature DB >> 28270544

Sedentary Behavior Is an Independent Predictor of Mortality in Subjects With COPD.

Karina C Furlanetto1, Leila Donária1, Lorena P Schneider1, José R Lopes1, Marcos Ribeiro1,2, Karen Bp Fernandes3, Nidia A Hernandes1, Fabio Pitta4.   

Abstract

BACKGROUND: The terms sedentary behavior and physical inactivity have been confusingly mixed. Although the association between physical inactivity and mortality has been shown previously in subjects with COPD, this association had not yet been investigated with regard to sedentarism. The aim of this work was to investigate the impact of sedentary behavior on mortality of subjects with COPD and to propose a cutoff point of sedentarism with prognostic value.
METHODS: In this retrospective cohort study, sedentary behavior was assessed with 2 activity monitors (DynaPort and Sensewear armband) in 101 subjects with COPD from 2006 to 2011. Vital status was then ascertained in 2015. The following 6 variables of sedentary behavior were analyzed: average of metabolic equivalent of task (MET)/d (reflecting intensity); time spent/d lying, sitting, and lying + sitting (reflecting duration of sedentary postures); and time spent/d in activities requiring <1.5 MET and <2 MET (reflecting intensity and duration of sedentary time). Cutoff points for sedentarism and their respective prognostic values were investigated for each variable.
RESULTS: Forty-one subjects (41%) died over a median (interquartile range) follow-up period of 62 (43-88) months. After adjusting for potential confounders in the Cox regression model, cutoff points from variables that combine duration of sedentary time and intensity <1.5 MET or <2 MET were associated with the increased risk of mortality. The strongest independent cutoff for predicting mortality was ≥8.5 h/d spent in sedentary activities <1.5 MET (area under the curve 0.76; hazard ratio 4.09, 95% CI 1.90-8.78; P < .001).
CONCLUSIONS: Sedentary behavior was an independent predictor of mortality in subjects with COPD, even adjusting for moderate-to-vigorous physical activity and a number of other variables. Mortality was higher in subjects with COPD who spend ≥8.5 h/d in activities requiring <1.5 MET. These findings may open room for future studies aiming at decreasing sedentary time as a promising strategy to reduce mortality risk in subjects with COPD.
Copyright © 2017 by Daedalus Enterprises.

Entities:  

Keywords:  chronic obstructive pulmonary disease; longitudinal studies; mortality; physical activity; sedentary lifestyle; survival analysis

Mesh:

Year:  2017        PMID: 28270544     DOI: 10.4187/respcare.05306

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  28 in total

1.  The London Chest Activity of Daily Living scale cut-off point to discriminate functional status in patients with chronic obstructive pulmonary disease.

Authors:  Aline Almeida Gulart; Anelise Bauer Munari; Suelen Roberta Klein; Raysa Silva Venâncio; Hellen Fontão Alexandre; Anamaria Fleig Mayer
Journal:  Braz J Phys Ther       Date:  2019-03-26       Impact factor: 3.377

2.  An observational study of self-reported sedentary behaviour in people with chronic obstructive pulmonary disease and bronchiectasis.

Authors:  Zoe J McKeough; Sarah L Large; Lissa M Spencer; Sonia W M Cheng; Renae J McNamara
Journal:  Braz J Phys Ther       Date:  2019-06-05       Impact factor: 3.377

3.  Objectively Measured Physical Activity in Patients with COPD: Recommendations from an International Task Force on Physical Activity.

Authors:  Heleen Demeyer; Divya Mohan; Chris Burtin; Anouk W Vaes; Matthew Heasley; Russell P Bowler; Richard Casaburi; Christopher B Cooper; Solange Corriol-Rohou; Anja Frei; Alan Hamilton; Nicholas S Hopkinson; Niklas Karlsson; William D-C Man; Marilyn L Moy; Fabio Pitta; Michael I Polkey; Milo Puhan; Stephen I Rennard; Carolyn L Rochester; Harry B Rossiter; Frank Sciurba; Sally Singh; Ruth Tal-Singer; Ioannis Vogiatzis; Henrik Watz; Rob Van Lummel; Jeremy Wyatt; Debora D Merrill; Martijn A Spruit; Judith Garcia-Aymerich; Thierry Troosters
Journal:  Chronic Obstr Pulm Dis       Date:  2021-10-28

4.  Differences in Sedentary Time, Light Physical Activity, and Steps Associated with Better COPD Quality of Life.

Authors:  C Noelle Driver; Paul J Novotny; Roberto P Benzo
Journal:  Chronic Obstr Pulm Dis       Date:  2022-01-27

5.  Effect of Using a Wheeled Walker on Physical Activity and Sedentary Time in People with Chronic Obstructive Pulmonary Disease: A Randomised Cross-Over Trial.

Authors:  Kylie Hill; L W Cindy Ng; Nola Cecins; Vittoria R Formico; Vinicius Cavalheri; Sue C Jenkins
Journal:  Lung       Date:  2019-12-11       Impact factor: 2.584

6.  Physical activity and sedentary time are related to clinically relevant health outcomes among adults with obstructive lung disease.

Authors:  Shilpa Dogra; Joshua Good; Matthew P Buman; Paul A Gardiner; Jennifer L Copeland; Michael K Stickland
Journal:  BMC Pulm Med       Date:  2018-06-07       Impact factor: 3.317

7.  Walking-based activity and sedentary behavior in Saudi males with chronic obstructive pulmonary disease.

Authors:  Mohammed M Alyami; Sue C Jenkins; Kylie Hill
Journal:  Saudi Med J       Date:  2018-05       Impact factor: 1.484

8.  Comparative assessment of ActiGraph data processing techniques for measuring sedentary behavior in adults with COPD.

Authors:  Katelyn E Webster; Natalie Colabianchi; Robert Ploutz-Snyder; Neha Gothe; Ellen Lavoie Smith; Janet L Larson
Journal:  Physiol Meas       Date:  2021-08-27       Impact factor: 2.688

9.  Physical chronic conditions, multimorbidity and sedentary behavior amongst middle-aged and older adults in six low- and middle-income countries.

Authors:  Davy Vancampfort; Brendon Stubbs; Ai Koyanagi
Journal:  Int J Behav Nutr Phys Act       Date:  2017-10-27       Impact factor: 6.457

10.  Improving physical activity, sedentary behaviour and sleep in COPD: perspectives of people with COPD and experts via a Delphi approach.

Authors:  Hayley Lewthwaite; Tanja W Effing; Anke Lenferink; Tim Olds; Marie T Williams
Journal:  PeerJ       Date:  2018-04-27       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.